Back
Safran SA Vs. NovoCure Industry Stock Comparison
Buy
52
SAFRF
Safran SA
Last Price:
$217.84
Seasonality Move:
3.78%
Sell
49
NVCR
NovoCure
Last Price:
$30.18
Seasonality Move:
-3.69%
Sell
49
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
-
NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SAFRF Stock Price Chart
NVCR Stock Price Chart
SAFRF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.39 | Sell |
Relative Strength Index (14 RSI): | 43.36 | Sell |
Chaikin Money Flow: | -194 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (216.38 - 228.32) | Sell |
Bollinger Bands (100): | (217.06 - 232.7) | Sell |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.94 | Buy |
Relative Strength Index (14 RSI): | 58.79 | Buy |
Chaikin Money Flow: | -60501 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.36 - 32.64) | Buy |
Bollinger Bands (100): | (14.38 - 25.86) | Buy |
SAFRF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 218.74 | Sell |
20-day SMA: | 219.58 | Sell |
50-day SMA: | 226.61 | Sell |
200-day SMA: | 223.32 | Sell |
8-day EMA: | 219.01 | Sell |
20-day EMA: | 220.98 | Sell |
50-day EMA: | 224.03 | Sell |
200-day EMA: | 217.29 | Buy |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.52 | Sell |
20-day SMA: | 30.41 | Sell |
50-day SMA: | 23.25 | Buy |
200-day SMA: | 18.89 | Buy |
8-day EMA: | 30.36 | Sell |
20-day EMA: | 29.22 | Buy |
50-day EMA: | 25.18 | Buy |
200-day EMA: | 21.21 | Buy |
Safran SA Earnings Growth & SAFRF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and an increase next year of $0.06 per share.
Safran SA Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |